- Global Pharma News & Resources

Global Protein Expression Market Report 2022 to 2027: Emergence of Microfluidics Presents Opportunities -

DUBLIN--(BUSINESS WIRE)--The "Global Protein Expression Market by Type (E.Coli, Mammalian, CHO, HEK 293, Insect, Pichia, Cell-free), Products (Reagents, Vectors, Competent Cells, Instruments, Service), Application (Therapeutic, Industrial), End User, and Region - Forecast to 2027" report has been added to's offering.

The global Protein Expression market is valued at an estimated USD 2.9 billion in 2022 and is projected to reach USD 5.4 billion by 2027, at a CAGR of 13.3% during the forecast period.

Factors such as the growth in the life science and biopharmaceutical industries, increasing research activities on recombinant-based protein expression, and the availability of funding for protein-based research. However, the high cost of protein expression reagents and instruments is expected to restrain the growth of this market.

The Prokaryotic Expression system segment accounted for the highest growth rate in the Protein Expression market, by System Type, during the forecast period

In 2021, the Prokaryotic Expression system segment accounted for the highest growth rate. Factors such as high level of protein production at a minimal cost, and their increasing applications in biologics production will favor the growth of this market.

Asia Pacific: The fastest-growing region in the Protein Expression market

The Asia Pacific market is estimated to record the highest CAGR during the forecast period. The high growth rate of this market can be attributed to the rapid growth of the biotechnology industry, the rising prevalence of chronic disorders, increasing investments by governments in protein-based research, and rising awareness about personalized therapeutics. Besides, global players are focused on this region for the low-cost manufacturing advantage that it provides.

Market Dynamics


  • Increasing Demand for Protein Biologics
  • Increasing R&D in Pharmaceutical and Biopharmaceutical Industries
  • Growing Adoption of Recombinant-Based Protein Expression
  • Availability of Funding for Protein-Based Research


  • High Cost of Protein Expression Reagents and Instruments
  • Increasing Consolidation and High Barriers for New Entrants


  • Emergence of Microfluidics
  • Emerging Economies Offering Significant Growth Potential


  • Undesired Post-Translational Modifications and Purification

Companies Mentioned

  • Thermo Fisher Scientific, Inc (US)
  • Merck KGaA (Germany)
  • GenScript Biotech Corporation (US)
  • Agilent Technologies, Inc. (US)
  • Takara Bio, Inc. (Japan)
  • Bio-Rad Laboratories, Inc. (US)
  • Qiagen N.V (Netherlands)
  • Charles River Laboratories, Inc. (US)
  • Danaher Corporation (US)
  • Sartorius AG (Germany)
  • Corning Incorporated (US)
  • FUJIFILM Irvine Scientific, Inc. (Japan)
  • Lonza Group AG (Switzerland)
  • Bioneer Corporation (South Korea)
  • Promega Corporation (US)
  • Oxford Expression Technologies Ltd. (UK)
  • ProteoGenix (France)
  • Abeomics, Inc. (US)
  • New England Biolabs, Inc. (US)
  • Promab Biotechnologies (US)
  • Sino Biological, Inc. (China)
  • Jena Bioscience (Germany)
  • Lifesensors, Inc. (US)
  • Leading biology, Inc. (US)
  • Peak Proteins (UK)

For more information about this report visit

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 02-Nov-2022